Breakthroughs and challenges in the management of tropomyosin receptor kinase fusion-positive tumors

被引：0

作者：

Mamdani, Hirva ^{[1
]}

Jalal, Shadia I. ^{[2
]}

机构：

[1] Wayne State Univ, Karmanos Canc Inst, 4100 John R, Detroit, MI 48201 USA

[2] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA

来源：

ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷

关键词：

TRK; ENTRECTINIB; INHIBITOR; ONCOGENE; ROS1;

D O I：

10.21037/atm.2019.06.41

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 27 条

[21] Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib The TRAC Randomized Clinical Trial [J].

Danilenko, Marina ;

Stamp, Elaine ;

Stocken, Deborah D. ;

Husain, Akhtar ;

Zangarini, Monique ;

Cranston, Amy ;

Stones, Robert ;

Sinclair, Naomi ;

Hodgson, Kirsty ;

Bowett, Susan A. ;

Roblin, David ;

Traversa, Silvio ;

Plummer, Ruth ;

Veal, Gareth ;

Langtry, James A. A. ;

Ashworth, Alan ;

Burn, John ;

Rajan, Neil .

JAMA DERMATOLOGY, 2018, 154 (08) :913-921

[22] PTCH1-GLI1 Fusion-Positive Ovarian Tumor: Report of a Unique Case With Response to Tyrosine Kinase Inhibitor Pazopanib [J].

Alwaqfi, Rofieda R. ;

Samuelson, Megan, I ;

Guseva, Natalya N. ;

Ouyang, Michelle ;

Bossler, Aaron D. ;

Ma, Deqin .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (09) :998-1004

[23] Tailored Approaches in the Treatment of Patients With Colorectal Cancer Harboring Tropomyosin Receptor Kinase Fusion and Microsatellite Instability-High: A Case Report and Literature Review [J].

Kim, Samuel ;

Itani, Malak ;

Liu, Xiuli ;

Sun, Lulu ;

Krysiak, Kilannin ;

Fox, Nicole ;

Firwana, Belal ;

Al Diffalha, Sameer ;

Manne, Upender ;

Seeber, Andreas ;

Karl, Molly ;

Frank, Michele ;

Stubblefield, Hannah ;

Pedersen, Katrina ;

Lim, Kian-Huat ;

Abushukair, Hassan ;

Khushman, Moh'd .

JCO PRECISION ONCOLOGY, 2025, 9

[24] Real-world experience of tropomyosin receptor kinase inhibition with entrectinib in ETV6-NTRK3 positive metastatic salivary secretory carcinoma: A case series [J].

Yokota, Tomoya ;

Yukino, Hiroki ;

Doi, Mihoko ;

Ohori, Hisatsugu .

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2023, 45 (05) :E10-E15

[25] Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A [J].

Guadagni, Stefano ;

Farina, Antonietta Rosella ;

Cappabianca, Lucia Annamaria ;

Sebastiano, Michela ;

Maccarone, Rita ;

Zelli, Veronica ;

Clementi, Marco ;

Chiominto, Alessandro ;

Bruera, Gemma ;

Ricevuto, Enrico ;

Fiorentini, Giammaria ;

Sarti, Donatella ;

Mackay, Andrew Reay .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) :1-17

[26] Comparison of Reverse Transcription-Polymerase Chain Reaction, Immunohistochemistry, and Fluorescence In Situ Hybridization Methodologies for Detection of Echinoderm Microtubule-Associated Proteinlike 4-Anaplastic Lymphoma Kinase Fusion-Positive Non-Small Cell Lung Carcinoma Implications for Optimal Clinical Testing [J].

Wallander, Michelle L. ;

Geiersbach, Katherine B. ;

Tripp, Sheryl R. ;

Layfield, Lester J. .

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2012, 136 (07) :796-803

[27] Apatinib reverses alectinib resistance by targeting vascular endothelial growth factor receptor 2 and attenuating the oncogenic signaling pathway in echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion gene-positive lung cancer cell lines [J].

Chen, Yanqiong ;

Ma, Guoliang ;

Su, Cuiyun ;

Wu, Pihua ;

Wang, Huilin ;

Song, Xiangqun ;

Yu, QiTao ;

Zeng, Aiping ;

Zhou, Shaozhang .

ANTI-CANCER DRUGS, 2018, 29 (10) :935-943

← 1 2 3 →